AERD Care Digest

Dupilumab Efficacy in AERD

• 🔥 Post-FESS Outcomes: A Best Practice review of five clinical trials shows dupilumab improves sinonasal outcomes in...

Climate change drives earlier (up to 20 days), longer, and more intense pollen seasons, worsening respiratory symptoms and sleep for AERD...

Key real-world gains for AERD patients with CRSwNP:

• Reduces nasal polyps and revision surgery needs
• Improves smell and congestion, tackling core...

Critical alert for AERD patients: Thunderstorms fracture mold spores, grass, and pollen, triggering severe asthma via concentrated allergens from...

Daily nasal irrigation and intranasal corticosteroid sprays remain the cornerstone of initial management for all CRSwNP patients, irrespective of disease—essential first step for AERD caregivers.

Practical tip for AERD travel: Hotel fabrics trap allergens like dust mites and pollen, releasing them into air to spark respiratory flares.

• Choose...

CRSwNP and AERD Overlaps

• 🔥 Asthma and aspirin sensitivity/AERD-like features frequently co-occur with CRSwNP and can shape endotype expression...

• Alt a 1 named the unseen culprit behind recurring respiratory woes
• Alternaria alternata particularly implicated in asthma and chronic sinusitis
• Highlights fungal allergens as potential AERD exacerbation triggers for patients to monitor

Multi-angle view for AERD patients:

• Asthma & aspirin sensitivity/AERD-like features frequently co-occur with CRSwNP, shaping endotype &...

Key warning for AERD patients on aspirin therapy (ATAD):

• Moderate interaction: Magnesium carbonate (Magonate) with aspirin decreases aspirin's...

Treatable traits model identifies specific drivers of asthma symptoms for targeted therapy.

Key examples:

• Eosinophilic inflammation, comorbid...

Boost indoor air for AERD relief — Texas A&M study shows simple changes reduce attacks in adults.

Actionable tips:

• Install exhaust fans in...

Promising short-term results for biologics in recalcitrant AFRS:

• SNOT-22, endoscopy, eosinophils, IgE all improved significantly across 60 patients...

VIBRANT Phase 2 Efficacy Highlights

• 🔥 Nasal Polyp Score Reduction: Verekitug showed a placebo-adjusted reduction of -1.95 in endoscopic nasal...

New analyses from Upstream Bio's VIBRANT trial highlight verekitug's potential for CRSwNP patients:

• NPS reduction: Placebo-adjusted -1.95 (p<0.0001,...

Biologics for Severe Asthma Remission

• 🔥 Lessons on Optimal Use: Review discusses T2-directed biologics enabling clinical remission in severe...

• Clinical remission possible with biologics: no systemic corticosteroids, no exacerbations, plus symptom/lung function control—but only a minority...

Real-world evidence from 3-year TriNetX data: GLP-1s (semaglutide, tirzepatide, liraglutide) linked to 12-15% fewer asthma exacerbations in...

Free VASMEP offers 6 one-on-one virtual sessions with workbook/app for accessible self-management:

• 78% improved ACT scores (avg +3.8 points) at 12...

Key win for moderate cases: New trial shows omalizumab + standard therapy beats standard alone in reducing Nasal Polyp Score (-2.1 vs -0.4 at 12...